Proactive investorsLogo Proactive Investors UK Website

Search field
Get Adobe Flash Player Download
Flash
Player ►

And
Enable
Javascript

1 year chart

digital-look imported chart image

1 day chart

digital-look imported chart image
Additional information
Additional Information
Market: ASX
Sector: Pharma & Biotech
Epic: POH
News: Latest news
Web Site: Phosphagenics Limited
Other Articles: 04-11-200915-09-200910-09-2009

RSS - Subscribe to the News Today on Proactive UK ▼

Monday March 15, 10:21Diamondcorp: a big cash injection and a lot of work to do

70% of the new money was raised from current shareholders, reflecting a hefty amount of faith in the management to deliver.

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive NA ▼

Monday March 15, 11:38Calvin Klein owner buys Tommy Hilfiger for US$3 billion from Apax Partners

The New York listed shirt and neckwear company is paying €1.924 billion in cash and issuing €276 million in PVH common stock (approximately 8.7 million shares) to fund the transaction.

 

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive CN ▼

Monday March 15, 08:01China's growth boosting commodity prices

The latest economic figures from China have put pressure on the dollar and boosted a number of high-yielding currencies, including the Australian dollar and the South African rand.

FULL ARTICLE ►
Phosphagenics Limited

Phosphagenics Limited

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and personal care products
Wednesday, November 04, 2009

Phosphagenics TPM delivery technology used by Le Métier de Beauté in US personal care product launch

company news image

Melbourne biotechnology company Phosphagenics (ASX: POH; OTCQX: PPGNY) announced today that the New York-based luxury beauty company, Le Métier de Beauté, will launch its new cosmetic treatment products, Peau de Vierge anti-aging collection, exclusively with Phosphagenics’ TPM delivery technology across the US this month.

To support the launch, Le Métier de Beauté will commence a significant marketing campaign focusing on Phosphagenics’ TPM delivery technology as the primary point of differentiation.

Phosphagenics core technology offering is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

In July, Phosphagenics announced that Le Métier de Beauté agreed to license to manufacture and sell products using Phosphagenics’ TPM technology.

The company said its strategy (outlined at the May AGM) to quickly and at low cost to the company, to enter the highly lucrative US personal care market has been achieved. 

The arrangement with Le Métier de Beauté will enable an entry into profitable personal care market, imiting the company's financial exposure and maintaining substantial financial upside. 

By partnering with Le Métier de Beauté, will allow Phosphagenics to remain focused on its core pharmaceutical development business.

AddThis Feed Button
Register here to be notified of Proactiveinvestors One2One Forums.

Other Phosphagenics Limited news

More news ►

Investors interested in Phosphagenics Limited recently viewed


No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.